Chinese Traditional and Herbal Drugs
|
2025, 56(23): 8850-8859
Research progress on classical formula Maimendong Decoction in treatment of lung cancer
Full
ZHU Ranpei1,2, YANG Yajing2, ZHAO Fangfang1,2, LI Chunguang1,2, ZHENG Yuling1
Affiliations
1 Department of Hematology and Oncology, First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450003, China;
2 Henan University of Chinese Medicine, Zhengzhou 450046, China
doi: 10.7501/j.issn.0253-2670.2025.23.033
Outline
Maimendong Decoction (麦门冬汤), derived from Synopsis of the Golden Chamber, possesses the effects of replenishing qi and nourishing yin, clearing heat, and moistening the lung and stomach. Originally formulated by Zhang Zhongjing for treating deficient heat lung flaccidity, it has been widely used in modern times for treating various lung-related diseases such as lung cancer, pneumonia, and lung abscess, with particularly definite efficacy in lung cancer. This paper sorts out Chinese and English literatures of the past 20 years and summarizes the relevant research on Maimendong Decoction in the treatment of lung cancer from three aspects: Basic formula syndrome, clinical research, and molecular mechanisms. It is found that Maimendong Decoction features mutual nourishment of the lung, spleen, and stomach (strengthening earth to generate metal), combining yin-nourishing and dryness-moistening effects, as well as integrating sweet-cold and sweet-warm herbs in its composition. It mainly treats syndromes of lung-stomach yin deficiency, with rigorous compatibility and precise medication. Clinical studies have shown that Maimendong Decoction can be combined with conventional western medicine treatments for lung cancer, such as molecular targeted therapy, chemotherapy, and radiotherapy, to alleviate adverse reactions, improve patients’ treatment response rate and quality of life, and prevent and manage lung cancer-related complications, with definite efficacy, safety, and suitability for long-term use. Mechanistic studies have revealed that Maimendong Decoction exerts anti-lung cancer effects by regulating the malignant biological behavior of lung cancer cells, reversing epithelial-mesenchymal transition (EMT), reducing lung cancer invasiveness, regulating non-coding RNAs, modulating immune disorders, and preventing radiation-induced injury, with clear molecular mechanisms. Furthermore, pharmacological studies have identified multiple anti-lung cancer active components in Maimendong Decoction, such as ophiopogonin D, ursolic acid, glabridin, and licorice chalcone A, which have been validated by in vivo and in vitro experiments. Through literature induction, this paper comprehensively and elaborately expounds the research status of Maimendong Decoction in treating lung cancer, points out the deficiencies and improvements of current research, and aims to provide ideas and evidence for the subsequent in-depth exploration of this formula and the new model of integrated traditional Chinese and Western medicine treatment for lung cancer.
Maimendong Decoction
/
lung cancer
/
classical formula
/
malignant tumor
/
ncRNA
/
ophiopogonin D
/
ursolic acid
/
glabridin
/
licorice chalcone A
朱燃培, 杨雅静, 赵方方, 李春光, 郑玉玲.
麦门冬汤治疗肺癌的研究进展.
中草药,
2025
, 56
(23)
: 8850
-8859
.
DOI: 10.7501/j.issn.0253-2670.2025.23.033
ZHU Ranpei, YANG Yajing, ZHAO Fangfang, LI Chunguang, ZHENG Yuling.
Research progress on classical formula Maimendong Decoction in treatment of lung cancer[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(23)
: 8850
-8859
.
DOI: 10.7501/j.issn.0253-2670.2025.23.033
Year 2025 volume 56 Issue 23
44
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.23.033
- Receive Date:2025-06-26
- Online Date:2026-11-13